These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20072881)

  • 21. Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells.
    White KL; Rades T; Furneaux RH; Tyler PC; Hook S
    J Pharm Pharmacol; 2006 Jun; 58(6):729-37. PubMed ID: 16734974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
    Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
    J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunological adjuvant and vaccine carrier properties of liposomes.
    Gregoriadis G
    J Drug Target; 1994; 2(5):351-6. PubMed ID: 7704478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elastic liposomes mediated transcutaneous immunization against Hepatitis B.
    Mishra D; Dubey V; Asthana A; Saraf DK; Jain NK
    Vaccine; 2006 May; 24(22):4847-55. PubMed ID: 16600441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
    Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
    Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes.
    Lu Y; Kawakami S; Yamashita F; Hashida M
    Biomaterials; 2007 Jul; 28(21):3255-62. PubMed ID: 17449093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the adjuvant and cytotoxic effects of the positive charges and polymerization in liposomes.
    Gasparri J; Speroni L; Chiaramoni NS; del Valle Alonso S
    J Liposome Res; 2011 Jun; 21(2):124-33. PubMed ID: 20550461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
    Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.
    Wilson KD; Raney SG; Sekirov L; Chikh G; deJong SD; Cullis PR; Tam YK
    Int Immunopharmacol; 2007 Aug; 7(8):1064-75. PubMed ID: 17570323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sperm membrane lipid liposomes can evoke an effective immune response against encapsulated antigen in BALB/c mice.
    Atif SM; Salam N; Ahmad N; Hasan IM; Jamal HS; Sudhanshu A; Azevedo V; Owais M
    Vaccine; 2008 Oct; 26(46):5874-82. PubMed ID: 18789993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposome-based vaccines.
    Schwendener RA; Ludewig B; Cerny A; Engler O
    Methods Mol Biol; 2010; 605():163-75. PubMed ID: 20072880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages.
    Tanaka Y; Kasai M; Taneichi M; Naito S; Kato H; Mori M; Nishida M; Maekawa N; Yamamura H; Komuro K; Uchida T
    Bioconjug Chem; 2004; 15(1):35-40. PubMed ID: 14733581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mannose-mediated targeted immunoadjuvant action of liposomes.
    Garcon N; Gregoriadis G; Taylor M; Summerfield J
    Immunology; 1988 Aug; 64(4):743-5. PubMed ID: 3169846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
    Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
    J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines.
    Johnston D; Zaidi B; Bystryn JC
    Cancer Immunol Immunother; 2007 Aug; 56(8):1133-41. PubMed ID: 17139492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.